Keyphrases
Pancreatic Cancer
100%
MicroRNA
100%
Rapamycin
100%
Metformin
100%
Pre-diabetes (pre-DM)
100%
Cancer Growth
100%
Tumor Growth
25%
Pancreatic Tumor
25%
Mammalian Target of Rapamycin (mTOR)
25%
MTOR Inhibitor
25%
Diet-induced Obesity
25%
Panc02
25%
C57BL
12%
Intervention Strategies
12%
Growth Inhibition
12%
Pancreatic Tumor Cells
12%
Diabetes
12%
Growth Signaling
12%
Decreased Risk
12%
Type 2 Diabetic Patients
12%
Better Prognosis
12%
Insulin Level
12%
Glucose Level
12%
Distinct Mechanism
12%
Survival Signaling
12%
Transplantation Model
12%
Glucose Regulation
12%
Cancer Inpatients
12%
Direct Target
12%
Mammalian Target of Rapamycin Pathway
12%
MicroRNA Expression
12%
Metformin Treatment
12%
Pathway Signaling
12%
Insulin Expression
12%
Cell Transplant
12%
Tumorsphere
12%
MicroRNA-34a (miR-34a)
12%
Risk Prognosis
12%
Let-7a
12%
Medicine and Dentistry
microRNA
100%
Glycon
100%
Pancreas Cancer
100%
Rapamycin
100%
Pancreas Tumor
33%
Mechanistic Target of Rapamycin
33%
Tumor Progression
22%
Mammalian Target of Rapamycin Inhibitor
22%
Notch
22%
Diet-Induced Obese
22%
C57BL/6
11%
Neoplasm
11%
In Vitro
11%
Growth Inhibition
11%
Tumor Cell
11%
Diabetes
11%
Cell Cycle
11%
Patient with Type 2 Diabetes
11%
Cell Signaling Pathway
11%
Impaired Glucose Tolerance
11%
Tumor Spheroid
11%
microRNA 34a
11%
Snail
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Pancreas Cancer
100%
microRNA
100%
Metformin
100%
Mammalian Target of Rapamycin
33%
Pancreas Tumor
33%
Tumor Growth
22%
Mammalian Target of Rapamycin Inhibitor
22%
Neoplasm
11%
C57BL 6 Mouse
11%
Impaired Glucose Tolerance
11%
microRNA 34a
11%
Non Insulin Dependent Diabetes Mellitus
11%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Mechanistic Target of Rapamycin
100%
Tumor Progression
40%
Notch
40%
C57BL 6 Mouse
20%
Cell Cycle
20%
Insulin Level
20%
Glucose Level
20%
Growth Inhibition
20%
Impaired Glucose Tolerance
20%
Tumor Spheroid
20%
Immunology and Microbiology
Sirolimus
100%
Notch
18%
C57BL 6 Mouse
9%
Tumor Cell
9%
Cell Cycle
9%
Growth Inhibition
9%
Glucose Level
9%
Tumor Spheroid
9%
Insulin Level
9%